サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1298646

治験管理システム市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
治験管理システム市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の治験管理システム市場規模は2022年に10億3,310万米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に11%の成長率（CAGR）を示し、2028年までに19億5,340万米ドルに達すると予測しています。効率的な臨床試験に対する需要の高まり、規制遵守を求める規制当局からの圧力の高まり、広範な研究開発活動が市場を牽引する主な要因となっています。

治験管理システム（CTMS）は、臨床試験プロセスを合理化するために広く利用されているコンピュータ操作のソフトウェアシステムです。コストを削減し、臨床試験結果の質と安全性を維持することで、企業が臨床試験をより効率的に管理できるように設計されています。患者データの追跡、臨床試験文書の管理、臨床試験活動の追跡、アポイントメントのスケジューリング、臨床試験実施施設とスポンサー間のコミュニケーション管理などのモジュールがあります。また、様々なレポートや分析オプションも提供しており、企業が臨床試験の実績をよりよく理解し、十分な情報に基づいた意思決定を行えるよう支援します。これらのサービスは、臨床試験結果を最高の品質と安全性で保証しながら、企業が臨床試験をより適切に管理できるよう支援します。臨床試験の複雑さが増しているため、世界中で治験管理システムの需要が大幅に増加しています。

治験管理システムの市場動向：

効率的な臨床試験に対する需要の高まりが、世界市場を大きく牽引しています。また、多くの製薬企業やバイオテクノロジー企業が、コスト削減と新治療法の市場開拓のスピードアップのため、臨床試験の効率化に注力しており、これが市場を後押ししています。治験管理システムは、臨床試験のプロセスを合理化し、エラーの数を減らし、全体的なデータ精度を向上させるのに役立つため、世界レベルでの需要を促進しています。患者にデータへのアクセスを提供し、臨床試験で自分のデータがどのように使用されているかを確認できるようにすることで、患者エンゲージメントを強化するという観点から、治験管理システムが広く採用されており、市場に好影響を与えています。これとともに、規制遵守を確実にするための規制機関からの圧力の高まりも、市場にプラスの影響を与えています。これに伴い、治験管理システムは、組織がデータ収集や報告などのすべての規制要件を効率的かつコスト効率よく満たすことを支援し、これがもう一つの成長促進要因として作用しています。さらに、効果的な臨床試験のためにヘルスケア組織と研究チーム間のコラボレーションを促進するCTMSの採用が拡大していることも、市場の前向きな見通しを生み出しています。市場を牽引するその他の要因としては、継続的な技術の進歩やヘルスケアインフラの継続的な改善などが挙げられます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 治験管理システムの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • ソフトウェア
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：導入形態別

  • WebベースCTMS
    • 市場動向
    • 市場予測
  • オンプレミス
    • 市場動向
    • 市場予測
  • クラウド型CTMS
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • 受託研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Advarra Inc.
    • ArisGlobal LLC
    • BioClinica Inc.
    • DataTrak International Inc.
    • DZS Clinical Services Inc.（WDB Holdings Co. Ltd.）
    • International Business Machines Corporation
    • Medidata Solutions Inc.（Dassault Systemes SE）
    • MedNet Solutions Inc.
    • Oracle Corporation
    • Parexel International Corporation
    • RealTime Software Solutions LLC
    • Veeva Systems Inc.
図表

List of Figures

  • Figure 1: Global: Clinical Trial Management Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Clinical Trial Management Systems Market: Breakup by Component (in %), 2022
  • Figure 5: Global: Clinical Trial Management Systems Market: Breakup by Deployment Mode (in %), 2022
  • Figure 6: Global: Clinical Trial Management Systems Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Clinical Trial Management Systems Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Clinical Trial Management Systems (Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Clinical Trial Management Systems (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Clinical Trial Management Systems (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Clinical Trial Management Systems (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Clinical Trial Management Systems (Web-based CTMS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Clinical Trial Management Systems (Web-based CTMS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Clinical Trial Management Systems (On-premise) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Clinical Trial Management Systems (On-premise) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Clinical Trial Management Systems (Cloud-based CTMS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Clinical Trial Management Systems (Cloud-based CTMS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Clinical Trial Management Systems (Pharmaceutical and Biotechnology Firms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Clinical Trial Management Systems (Pharmaceutical and Biotechnology Firms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Clinical Trial Management Systems (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Clinical Trial Management Systems (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Clinical Trial Management Systems (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Clinical Trial Management Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Clinical Trial Management Systems Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Clinical Trial Management Systems Industry: SWOT Analysis
  • Figure 74: Global: Clinical Trial Management Systems Industry: Value Chain Analysis
  • Figure 75: Global: Clinical Trial Management Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Management Systems Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Clinical Trial Management Systems Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: Clinical Trial Management Systems Market Forecast: Breakup by Deployment Mode (in Million US$), 2023-2028
  • Table 4: Global: Clinical Trial Management Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Clinical Trial Management Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Clinical Trial Management Systems Market: Competitive Structure
  • Table 7: Global: Clinical Trial Management Systems Market: Key Players
目次
Product Code: SR112023A4984

The global clinical trial management systems market size reached US$ 1,033.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,953.4 Million by 2028, exhibiting a growth rate (CAGR) of 11% during 2023-2028. The growing demand for efficient clinical trials, rising pressure from regulatory agencies to ensure compliance with regulations, and extensive research and development activities represent some of the key factors driving the market.

Clinical trial management systems (CTMS) are computer-operated software systems that are widely utilized to streamline the clinical trial process. They are designed to help companies manage their clinical trials more efficiently by reducing costs and maintaining the quality and safety of the trial results. They have modules for tracking patient data, managing clinical trial documents, tracking clinical trial activities, scheduling appointments, and managing communication between clinical trial sites and sponsors. They also provide a variety of reports and analytics options to assist companies in better understanding the clinical trial performance and making informed decisions. They aid companies in better managing their clinical trials while ensuring the clinical trial results are of the highest quality and safety. Due to the increasing complexities in clinical trials, there has been a considerable increase in the demand for clinical trial management systems across the globe.

Clinical Trial Management Systems Market Trends:

The escalating demand for efficient clinical trials majorly drives the global market. Additionally, numerous pharmaceutical and biotechnology companies are focusing on improving the efficiency of their clinical trials, in order to reduce costs and speed up the development of new treatments, which is providing a boost to the market. Since, clinical trial management systems help to streamline clinical trial processes, reduce the number of errors, and improve overall data accuracy, are propelling demand on the global level. With the widespread adoption of clinical trial management systems with a view to enhancing patient engagement by providing patients with access to their data and allowing them to see how their data is being used in the clinical trial is impacting the market favorably. Along with this, the rising pressure from regulatory agencies to ensure compliance with regulations is also positively influencing the market. In line with this, clinical trial management systems help organizations to ensure that they meet all regulatory requirements, such as data collection and reporting, efficiently and cost-effectively, which is acting as another growth-inducing factor. Furthermore, the growing adoption of CTMS to facilitate collaboration between healthcare organizations and research teams for effective clinical trials is creating a positive market outlook. Some of the other factors driving the market include continual technological advancements and continual improvements in healthcare infrastructure.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial management systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, deployment mode and end user.

Component Insights:

Software

Services

The report has provided a detailed breakup and analysis of the clinical trial management systems market based on the component. This includes software and services. According to the report, software is dominating the total market share.

Deployment Mode Insights:

Web-based CTMS

On-premise

Cloud-based CTMS

A detailed breakup and analysis of the clinical trial management systems market based on the deployment mode have also been provided in the report. This includes web-based CTMS, on-premise, and cloud-based CTMS. According to the report, web-based CTMS accounted for the largest market.

End User Insights:

Pharmaceutical and Biotechnology Firms

Contract Research Organizations

Others

The report has provided a detailed breakup and analysis of the clinical trial management systems market based on the component. This includes pharmaceutical and biotechnology firms, contract research organizations, and others. according to the report, pharmaceutical and biotechnology firms represent the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America holds the leading position in the market for clinical trial management systems. Some of the factors driving the North America clinical trial management systems market included continual technological advancements and the presence of large players.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global clinical trial management systems market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systemes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC and Veeva Systems Inc.

Key Questions Answered in This Report

1. What was the size of the global clinical trial management systems market in 2022?

2. What is the expected growth rate of the global clinical trial management systems market during 2023-2028?

3. What has been the impact of COVID-19 on the global clinical trial management systems market?

4. What are the key factors driving the global clinical trial management systems market?

5. What is the breakup of the global clinical trial management systems market based on the component?

6. What is the breakup of the global clinical trial management systems market based on the deployment mode?

7. What is the breakup of the global clinical trial management systems market based on the end user?

8. What are the key regions in the global clinical trial management systems market?

9. Who are the key players/companies in the global clinical trial management systems market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Clinical Trial Management Systems Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Component

  • 6.1  Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7   Market Breakup by Deployment Mode

  • 7.1  Web-based CTMS
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  On-premise
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Cloud-based CTMS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Pharmaceutical and Biotechnology Firms
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Advarra Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  ArisGlobal LLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3  BioClinica Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4  DataTrak International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  International Business Machines Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Medidata Solutions Inc. (Dassault Systemes SE)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  MedNet Solutions Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Oracle Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Parexel International Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11  RealTime Software Solutions LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12  Veeva Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis